Question 1

What is the catalog number for Embryonic connective tissue from human foetus, sec.?

Accepted Answer

The catalog number for Embryonic connective tissue from human foetus, sec. is Ho126d.

Question 2

What sizes are available for Embryonic connective tissue from human foetus, sec.?

Accepted Answer

Embryonic connective tissue from human foetus, sec. is available in the following size(s): 7.6 x 2.6 cm.

Question 3

Is Embryonic connective tissue from human foetus, sec. in stock?

Accepted Answer

Embryonic connective tissue from human foetus, sec. is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is Embryonic connective tissue from human foetus, sec. used for?

Accepted Answer

Embryonic connective tissue from human foetus, sec.

Question 5

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 6

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 7

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

Embryonic connective tissue from human foetus, sec.

Product Specifications

HS Code

Weight

Product Group 1

Product Group 2

Product Group 3

Frequently Asked Questions

Explore Other Products

Anti-FOXJ2 Antibody Picoband®

Anti-BAFF/TNFSF13B Antibody Picoband®, Carrier-free

GAD2 / GAD65 (GABAergic Neuronal Marker) (GAD2/1960), CF488A conjugate, 0.1mg/mL

Anti-Yes1 Rabbit Monoclonal Antibody

Cytokeratin 5/6/18 (LP34), CF594 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2741), 0.2mg/mL